Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A recent study from Prime Therapeutics found that nearly half of patients discontinue GLP-1 therapy within the first year, and three out of four stop treatment by year two
It's a good option if you struggle to get enough fiber from your diet
Novo and Eli Lilly are the two early leaders in the obesity spaceand are anticipated to control around 80% of the marketbut, like Merck, several other biopharma players are vying for a spot in the GLP-1 game
Visit any of our five Memphis-area locations or book an appointment online to start your journey toward renewed vitality.
JCM extension 2006;91(3):799-805
US$ 27.63
US$ 24.65
US$ 22.69
US$ 29.22
US$ 21.83
US$ 23.07
